Commentary
Obesity has become a crisis in the United States, with 42 percent of adults and 20 percent of children classified as obese. The government’s recent proposal to cover weight loss drugs under Medicare and Medicaid marks a pivotal moment in how we approach this epidemic. While these medications offer short-term solutions for some, their widespread adoption could have devastating consequences for public health, financial sustainability, and the future of preventive care.
